To evaluate the existence of ROR1-reactive T cells in circulating immune cells, PBMCs from patients with HNSCC and healthy individuals were stimulated with the ROR1403–417 peptide. The gene discussed is ROR1; the disease is head and neck squamous cell carcinoma.